OrthoPediatrics Corp.
DE ˙ DB ˙ US68752L1008
15,50 € ↑1,50 (10,71%)
2026-06-05
CENA AKCJI
SecurityDE:2X7 / OrthoPediatrics Corp.
InstitutionWasatch Advisors Inc
Latest Disclosed Ownership329,320 shares
Latest Disclosed Value $ 5,226,308
Wasatch Advisors Inc reports 13.61% increase in ownership of 2X7 / OrthoPediatrics Corp.

On April 21, 2026 - Wasatch Advisors Inc filed a 13F-HR form disclosing ownership of 329,320 shares of OrthoPediatrics Corp. (DE:2X7) valued at $4,281,160 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 289,869 shares of OrthoPediatrics Corp.. This represents a change in shares of 13.61% during the quarter. The current value of the position is $5,104,460 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F ORTHOPEDIATRICS COM 68752L100 329,320 39,451 13.61 5,226 1.52 0.0347
2026-02-12 2025-12-31 13F ORTHOPEDIATRICS COM 68752L100 289,869 -14,242 -4.68 5,148 -8.64
2025-11-14 2025-09-30 13F ORTHOPEDIATRICS COM 68752L100 304,111 -11,543 -3.66 5,635 -16.89 0.0303
2025-08-14 2025-06-30 13F ORTHOPEDIATRICS COM 68752L100 315,654 -402,223 -56.03 6,780 -61.65 0.0355
2025-05-15 2025-03-31 13F ORTHOPEDIATRICS COM 68752L100 717,877 21,559 3.10 17,681 9.55 0.0986
2025-02-13 2024-12-31 13F ORTHOPEDIATRICS COM 68752L100 696,318 223,217 47.18 16,141 25.85 0.0799
2024-11-14 2024-09-30 13F ORTHOPEDIATRICS COM 68752L100 473,101 -62,195 -11.62 12,826 -16.69 0.0629
2024-08-14 2024-06-30 13F ORTHOPEDIATRICS COM 68752L100 535,296 33,986 6.78 15,395 5.32 0.0823
2024-04-18 2024-03-31 13F ORTHOPEDIATRICS COM 68752L100 501,310 87,657 21.19 14,618 8.71 0.0764
2024-02-14 2023-12-31 13F ORTHOPEDIATRICS COM 68752L100 413,653 26,073 6.73 13,448 8.43 0.0741
2023-11-14 2023-09-30 13F ORTHOPEDIATRICS COM 68752L100 387,580 -18,076 -4.46 12,403 -30.28 0.0784
2023-08-08 2023-06-30 13F ORTHOPEDIATRICS COM 68752L100 405,656 14,345 3.67 17,788 2.64 0.1077
2023-05-12 2023-03-31 13F ORTHOPEDIATRICS COM 68752L100 391,311 5,176 1.34 17,331 12.97 0.1079
2023-02-14 2022-12-31 13F ORTHOPEDIATRICS COM 68752L100 386,135 243 0.06 15,341 -13.84 0.1033
2022-11-14 2022-09-30 13F ORTHOPEDIATRICS COM 68752L100 385,892 -70,317 -15.41 17,805 -9.55 0.1237
2022-08-12 2022-06-30 13F ORTHOPEDIATRICS COM 68752L100 456,209 -26,855 -5.56 19,685 -24.52 0.1244
2022-05-13 2022-03-31 13F ORTHOPEDIATRICS COM 68752L100 483,064 -16,373 -3.28 26,081 -12.76 0.1284
2022-02-15 2021-12-31 13F OrthoPediatrics COM 68752L100 499,437 4,503 0.91 29,896 -7.79 0.1220
2021-11-12 2021-09-30 13F ORTHOPEDIATRICS COM 68752L100 494,934 -74,287 -13.05 32,423 -9.84 0.1318
2021-08-12 2021-06-30 13F ORTHOPEDIATRICS COM 68752L100 569,221 -113,639 -16.64 35,963 8.03 0.1460
2021-05-10 2021-03-31 13F ORTHOPEDIATRICS COM 68752L100 682,860 271,528 66.01 33,289 96.20 0.1495
2021-02-12 2020-12-31 13F ORTHOPEDIATRICS COM 68752L100 411,332 46,758 12.83 16,967 1.35 0.0835
2020-11-10 2020-09-30 13F ORTHOPEDIATRICS COM 68752L100 364,574 -40,639 -10.03 16,741 -5.59 0.1065
2020-08-12 2020-06-30 13F ORTHOPEDIATRICS COM 68752L100 405,213 108,941 36.77 17,732 50.99 0.1283
2020-05-08 2020-03-31 13F ORTHOPEDIATRICS COM 68752L100 296,272 -67,607 -18.58 11,744 -31.32 0.1223
2020-02-13 2019-12-31 13F ORTHOPEDIATRICS COM 68752L100 363,879 2,993 0.83 17,099 34.37 0.1402
2019-11-14 2019-09-30 13F ORTHOPEDIATRICS COM 68752L100 360,886 13,288 3.82 12,725 -6.13 0.1212
2019-08-07 2019-06-30 13F ORTHOPEDIATRICS COM 68752L100 347,598 76,534 28.23 13,556 13.07 0.1321
2019-05-08 2019-03-31 13F ORTHOPEDIATRICS COM 68752L100 271,064 -86,300 -24.15 11,989 -3.82 0.1307
2019-02-14 2018-12-31 13F ORTHOPEDIATRICS COM 68752L100 357,364 -20,988 -5.55 12,465 -10.08 0.1661
2018-11-07 2018-09-30 13F OrthoPediatrics COM 68752L100 378,352 -22,697 -5.66 13,863 29.75 0.1584
2018-08-02 2018-06-30 13F OrthoPediatrics COM 68752L100 401,049 165,234 70.07 10,684 200.87 0.1286
2018-05-02 2018-03-31 13F OrthoPediatrics COM 68752L100 235,815 74,666 46.33 3,551 14.84 0.0459
2018-01-16 2017-12-31 13F OrthoPediatrics COM 68752L100 161,149 161,149 3,092 0.0410
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.